China Health Industries Holdings, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021	FY2020 12 months to Jun 30, 2020	FY2019 12 months to Jun 30, 2019
Cash Flows from Operating Activities
Net loss attributable to China Health Industries Holdings
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expenses
Provision for doubtful accounts
Deferred taxes gain
Changes in operating assets and liabilities:
Inventory
Accounts receivable
Other receivables
Advance to suppliers and prepaid expenses
Prepaid investment funds
Accounts payables and accrued expenses
Advance from customers and other payables
Amounts due to related parties
Wages payable
Taxes payable
Net cash provided by operating activities
Cash Flows from Investing Activities
Purchase of property, plant and equipment
Expenditure in construction in progress
Disposal of property, plant and equipment
Net cash (used in)/provided by investing activities

Cash Flows from Financing Activities
Effect of exchange rates change on cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Effect of exchange rates change on cash and cash equivalents
Net (decrease)/increase in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of cash flow information
Taxes paid
Non-cash activities:
Loan from related party for the construction of a facility

Comments